Возраст домена | 16 лет |
Дата окончания | Истек срок регистрации |
PR | 4 |
ИКС | |
Страниц в Google | 1060 |
Страниц в Яндексе | 13 |
Dmoz | ![]() |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 909642 |
Alexa Country | ![]() |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
B3C newswire | Biotech and Pharma News Distribution
biotech, pharma, press release, distribution, news release, newswire, pharmaceutical, biotechnology, trade media, B3C newswire
The biotech press release distribution service with the largest reach in biotech/pharma trade media worldwide.
UTF-8
431.79 КБ
2 500
58 225 симв.
48 877 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
![]() ![]() |
18 | 9 |
0 | 25 | ![]() | |
![]() ![]() |
15 | 9 |
0 | 5 | ![]() | |
![]() ![]() |
11 | 6 |
40 | 172280 | ![]() | |
![]() ![]() |
10 | 6 |
0 | 117924 | ![]() | |
![]() ![]() |
10 | 8 |
0 | 4165 | ![]() | |
![]() ![]() |
9 | 9 |
0 | 2 | ![]() | |
![]() ![]() |
8 | 9 |
0 | 3 | ![]() | |
![]() ![]() |
8 | 8 |
0 | 113 | ![]() | |
![]() |
8 | 7 |
0 | 6002756 | ![]() |
|
![]() ![]() |
6 | 7 |
0 | 25815 | ![]() | |
![]() ![]() |
3 | 6 |
0 | 2667 | ![]() | |
![]() |
1 | 6 |
0 | 1121 | ![]() | |
![]() |
1 | 3 |
0 | 101566 | ![]() | |
![]() ![]() |
1 | 1 |
50 | 18188211 | ![]() |
|
![]() |
1 | 1 |
0 | 191215 | ![]() | |
![]() ![]() ![]() |
1 | 2 |
70 | 696422 | ![]() | |
![]() ![]() |
1 | 6 |
0 | 9605 | ![]() | |
![]() |
1 | 3 |
10 | 6293510 | ![]() |
|
![]() ![]() |
1 | 7 |
0 | 1751 | ![]() | |
![]() |
1 | 4 |
90 | 1121394 | ![]() | |
Еще 30 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
![]() | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 13 Ноября 2013 ) | |
Количество ссылок на сайт | 131 |
Количество доменов, которые ссылаются на сайт | 43 |
Количество найденных анкоров | 27 |
Исходящие (внешние) ссылки домена | 437 |
Количество доменов, на которые ссылается сайт | 138 |
Количество исходящих анкоров | 28 |
Внутренние ссылки главной страницы ( 414 ) | |
# | Next |
/b3c-newswire-i.html?format=feed | <img> |
/about-us.html | ABOUT US |
/specialized-channels.html | SPECIALIZED CHANNELS |
/benefits.html | BENEFITS |
/references.html | REFERENCES |
/biotech-news-app-from-b3c-newswire.html | BIOTECH NEWS APP |
/partners.html | PARTNERS |
/newsletter-archive/ | NEWSLETTER ARCHIVE |
/index.php?option=com_chronoforms5&view=form&Itemid=228&lang... | EDITOR SIGN-UP |
/contact.html | CONTACT |
/terms-and-conditions.html | TERMS & CONDITIONS |
/index.php?option=com_chronoforms5&view=form&Itemid=217&lang... | Request a Demo |
/201912022007/biomed-x-reaches-milestone-in-respiratory-dise... | BioMed X Reaches Milestone in Respiratory Disease Research Collaboration with Boehringer Ingelheim |
/201911252006/vaccitech-provides-update-on-clinical-progress... | Vaccitech Provides Update on Clinical Progress for its Two Phase 2 Universal Influenza Studies |
/201911222005/halix-celebrates-grand-opening-of-its-state-of... | HALIX Celebrates Grand Opening of its State-of-the-Art cGMP Facility |
/201911212004/mc2-therapeutics-announces-fda-acceptance-of-i... | MC2 Therapeutics Announces FDA Acceptance of its New Drug Application for Wynzora™ Cream for Treatment of Plaque Psoriasis |
/201911182003/securecell-introduces-sephara-a-novel-silicon-... | Securecell Introduces Sephara, a Novel, Silicon-Based In-Situ Filtration Membrane |
/201911122002/directedluck-a-transposase-for-efficient-gene-... | DirectedLuck, a Transposase for Efficient Gene Delivery and High-Titer Cell Line Development |
/201911122001/zontal-space-disruptive-technologies-pave-the-... | ZONTAL Space – Disruptive Technologies Pave the Path to the Lab of the Future |
/201911112000/evitria-opens-its-new-head-office-in-scandinav... | evitria Opens its New Head Office in Scandinavia |
/201911081999/abcam-and-brickbio-announce-a-partnership-to-i... | Abcam and BrickBio Announce a Partnership to Incorporate Conjugation-Ready Sites into Recombinant Antibodies Across Abcam’s Port... |
/201911071998/sotio-exercises-second-target-option-under-exi... | SOTIO Exercises Second Target Option Under Existing Collaboration with NBE-Therapeutics to Develop Next-Generation Antibody-Drug... |
/201911051997/scirhom-initiates-first-in-class-antibody-deve... | SciRhom Initiates First-In-Class Antibody Development Program to Treat Major Autoimmune Diseases |
/201911041996/ichnos-sciences-announces-completion-of-enroll... | Ichnos Sciences Announces Completion of Enrollment of Phase 2b Trials for Two Investigational Therapies - ISB 830 And ISC 27864 |
/201910301995/vetter-provides-greater-flexibility-in-seconda... | Vetter Provides Greater Flexibility in Secondary Packaging Through Collaborative Work |
/201910301994/seranovo-enters-into-license-agreement-with-ca... | SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor |
/201910301993/tsi-reports-enrollment-of-first-10-patients-in... | TSI Reports Enrollment of First 10 Patients in its Phase 2 Ischemic Stroke Clinical Trial and Completion of its Phase 2 Study Pr... |
/201910291992/bioversys-receives-carb-x-award-of-up-to-us-8-... | BioVersys Receives CARB-X Award of up to US$ 8.92 Million for Development of Novel Antimicrobial Therapies |
/201910281991/biomed-x-completes-alzheimer-s-disease-researc... | BioMed X Completes Alzheimer’s Disease Research Project |
/201910231990/shuwen-biotech-designated-as-an-international-... | Shuwen Biotech Designated as an International Cooperation Base for Medical Diagnostic Technologies |
/201910211989/sartorius-stedim-biotech-launches-new-sartoche... | Sartorius Stedim Biotech Launches New Sartocheck® 5 Plus Filter Tester |
/201910211988/bd-launches-bd-intevia-1ml-two-step-disposable... | BD Launches BD Intevia™ 1mL Two-step Disposable Autoinjector – A Robust Platform Device Combining Autoinjector and Pre-Fillable ... |
/201910171987/heparegenix-gmbh-announces-management-changes.... | HepaRegeniX GmbH Announces Management Changes |
/201910161986/amarna-therapeutics-raises-10-million-to-progr... | Amarna Therapeutics Raises €10 Million to Progress Lead Development Candidate into Clinical Trials and Appoints a New Supervisor... |
/201910141985/ppf-and-sotio-invest-6-5-million-in-maverix-on... | PPF and SOTIO Invest $6.5 Million in MaveriX Oncology and its Lead Program MVX-5005 |
/201910111984/ime-medical-electrospinning-appoints-three-sea... | IME Medical Electrospinning Appoints Three Seasoned Medtech and Biopharmeutical Industry Experts to its Board of Directors |
/201910101983/clinigen-launches-managed-access-program-for-p... | Clinigen Launches Managed Access Program for Progenics Pharmaceuticals for AZEDRA® Outside the US |
/201910081982/nbe-therapeutics-appoints-dr-steffen-heeger-as... | NBE-Therapeutics Appoints Dr. Steffen Heeger as Chief Medical Officer for Leading The Clinical Development of NBE’s iADC Program... |
/201910071981/haselmeier-signs-an-exclusive-agreement-with-s... | Haselmeier Signs an Exclusive Agreement with Stevanato Group to License Axis-D Pen-injector Technology and Intellectual Property... |
/201910011979/probiogen-and-ceva-sante-animale-sign-an-exclu... | ProBioGen and Ceva Santé Animale Sign an Exclusive License Agreement to Produce Vectorised Poultry Vaccines Using AGE1.CR® Produ... |
/201910011980/mimetas-and-hubrecht-organoid-technologies-to-... | MIMETAS and Hubrecht Organoid Technologies to Develop and Market Organoids-on-a-Chip |
/201909261978/genewiz-celebrates-opening-of-european-headqua... | GENEWIZ Celebrates Opening of European Headquarters in Germany |
/201909261977/closing-of-financing-round-and-strengthening-o... | Closing of Financing Round and Strengthening of Development Team Paves the Way for T3 Pharma to Enter the Clinic |
/201909251976/nst-doses-first-patient-in-phase-2b-clinical-s... | NST Doses First Patient in Phase 2b Clinical Study of Icosabutate in NASH (‘ICONA’) |
/201909231975/biomed-x-successfully-completes-collaboration-... | BioMed X Successfully Completes Collaboration on Development of Nanomaterial-based Biosensors for Near-patient Testing |
/201909191974/mimetas-chairman-of-the-board-herbert-heyneker... | Mimetas Chairman of the Board Herbert Heyneker Receives Dutch Royal Honor |
/201909181973/vetter-s-chicago-site-wins-award-one-of-best-a... | Vetter’s Chicago Site Wins Award ‘One of Best and Brightest Companies to Work For®’ |
/201909171972/polyganics-achieves-positive-3-month-follow-up... | Polyganics Achieves Positive 3-month Follow-up Data of ENCASE I, the First Clinical Trial for LIQOSEAL® |
/201909161971/ppf-expands-its-investment-in-the-healthcare-s... | PPF Expands its Investment in the Healthcare Sector Through Acquisition of Significant Stake in T Cell Therapy Company Autolus T... |
/201909101969/probiogen-licenses-glymaxx-technology-to-bayer... | ProBioGen Licenses GlymaxX® Technology to Bayer |
/201909101968/noscendo-reaches-ce-certification-as-key-miles... | Noscendo Reaches CE Certification as Key Milestone for its Proprietary Diagnostic Platform DISQVER® and Conducts Successful Pilo... |
/201908301967/mario-polywka-joins-orbit-discovery-s-board-of... | Mario Polywka Joins Orbit Discovery’s Board of Directors |
/201908281966/rfxcel-the-global-leader-in-track-and-trace-so... | rfxcel, the Global Leader in Track and Trace Solutions, Continues Rapid Growth in Russia, Doubling the Size of Its Team, Enterin... |
/201908271965/velabs-therapeutics-enters-into-a-screening-co... | Velabs Therapeutics Enters into a Screening Cooperation with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody... |
/201908271964/vaccitech-appoints-bill-enright-as-new-chief-e... | Vaccitech Appoints Bill Enright as New Chief Executive Officer |
/201908221963/rfxcel-will-exhibit-at-cphi-middle-east-africa... | rfxcel Will Exhibit at CPhI Middle East & Africa, the Largest Pharmaceutical Event in the Region |
/201908221962/denovomatrix-introduces-ready-to-use-chemicall... | denovoMATRIX Introduces Ready-To-Use, Chemically Defined Coated Cell Cultureware for Serum-Free hMSC Expansion |
/201908211961/atelerix-consortium-awarded-267-000-innovate-u... | Atelerix Consortium Awarded £267,000 Innovate UK Grant for Collaboration with the Cell and Gene Therapy Catapult and Rexgenero o... |
/201908091960/halix-starts-operational-production-with-new-c... | HALIX Starts Operational Production with New cGMP Facility in Q4-2019 |
/201908081959/sartorius-stedim-biotech-launches-new-services... | Sartorius Stedim Biotech Launches New Services for Mammalian Cell Bank Manufacturing |
/201908051958/cytena-gmbh-announces-that-it-has-been-entered... | Cytena GmbH Announces That It Has Been Entered into an Agreement to Be Acquired by CELLINK |
/201907181956/results-of-the-pivotal-phase-3-study-of-the-be... | Results of the Pivotal Phase 3 Study of the Bempedoic Acid / Ezetimibe Combination Tablet Published in the European Journal of P... |
/201907231957/cytena-founds-subsidiary-in-taiwan.html | Cytena Founds Subsidiary in Taiwan |
/201907111955/sotio-initiates-first-in-human-clinical-trial-... | SOTIO Initiates First-In-Human Clinical Trial with IL-15 Superagonist SO-C101 |
/201907081953/prestige-biopharma-releases-positive-results-f... | Prestige BioPharma Releases Positive Results from Phase I Study of HD204, Biosimilar Candidate to Bevacizumab |
/201907081952/prestige-biopharma-and-pharmapark-announce-lic... | Prestige Biopharma and Pharmapark Announce License and Supply Agreement to Commercialize Prestige's Trastuzumab Biosimilar in th... |
/201907031951/confo-therapeutics-and-dynabind-announce-drug-... | Confo Therapeutics and DyNAbind Announce Drug Discovery Collaboration to Identify Novel GPCR-Modulating Compounds |
/201906281950/new-biotage-vacmaster-disk-vacuum-extraction-w... | New Biotage® VacMaster™ Disk - Vacuum Extraction with Rugged Versatility |
/201906271949/velabs-therapeutics-announces-3-million-series... | Velabs Therapeutics Announces €3 Million Series B Financing to Advance its Functional Antibody Screening Programme |
/201906271948/new-ambr-250-modular-bioreactor-vessel-launche... | New ambr® 250 Modular Bioreactor Vessel Launched for Cell and Gene Therapy Applications |
/201906261947/mammaprint-becomes-only-molecular-diagnostic-r... | MammaPrint® Becomes Only Molecular Diagnostic Recommended for Early-Stage Node-Positive Breast Cancer Patients in ASCO-Endorsed ... |
/201906241946/prestige-biopharma-reports-positive-top-line-p... | Prestige BioPharma Reports Positive Top-Line Phase III Results for Tuznue® (Trastuzumab Biosimilar) |
/201906241945/clinigen-broadens-partnership-with-accord-heal... | Clinigen Broadens Partnership with Accord Healthcare to Supply and Distribute Cardioxane® and Savene® in Poland |
/201906201944/agendia-announces-publication-of-study-validat... | Agendia Announces Publication of Study Validating Use of MammaPrint and BluePrint Molecular Diagnostics using Targeted RNA Next-... |
/201906171943/phase-2-trial-shows-efficacy-of-cytuvax-s-adju... | Phase 2 Trial Shows Efficacy of CyTuVax’s Adjuvant Platform Technology |
/201906171942/osteolabs-gmbh-successfully-closes-seed-financ... | Osteolabs GmbH Successfully Closes Seed Financing Round |
/201906111941/saga-raises-40-million-sek-3-7-million-to-adva... | SAGA Raises 40 Million SEK (€3.7 Million) To Advance Ultrasensitive Cancer Liquid Biopsies |
/201906051940/arivis-presents-the-new-vision4d-3-1-release-f... | arivis Presents the New Vision4D 3.1 Release for Working with Multi-Dimensional Big Image Data |
/201906041939/strategic-collaboration-between-biotage-and-yi... | Strategic Collaboration between Biotage and Yingsheng on the Chinese Market for Clinical Mass Spectrometry Applications |
/201906041938/apceth-will-operate-as-the-commercial-manufact... | apceth Will Operate as the Commercial Manufacturer in Europe for Zynteglo™, bluebird bio’s Gene Therapy for β-Thalassemia |
/201906021936/sotio-s-dcvac-luca-significantly-improves-surv... | SOTIO’s DCVAC/LuCa Significantly Improves Survival in Patients with Stage IV Non-small Cell Lung Cancer |
/201906011937/blueprint-identifies-genomic-subtypes-for-afri... | BluePrint® Identifies Genomic Subtypes for African-American Breast Cancer Patients with Low Risk Outcomes |
/201905281935/vetter-works-towards-a-sustainable-energy-supp... | Vetter Works Towards a Sustainable Energy Supply |
/201905281934/european-medicines-agency-accepts-marketing-au... | European Medicines Agency Accepts Marketing Authorisation Application for Prestige BioPharma’s Trastuzumab Biosimilar HD201 for ... |
/201905231933/probiogen-and-abcuro-signed-glymaxx-improved-c... | ProBioGen and Abcuro Signed GlymaxX®-Improved Cell Line Development and GMP Production Agreement |
/201905211932/agendia-and-imegen-announce-an-exclusive-distr... | Agendia and Imegen Announce an Exclusive Distribution Agreement for MammaPrint® and BluePrint® in Spain and Portugal |
/201905211931/ime-medical-electrospinning-launches-medispin-... | IME Medical Electrospinning Launches MediSpin XL™, a Cutting-Edge High-Volume Electrospinning Production Platform for Medical De... |
/201905201930/sotio-to-present-final-phase-i-ii-dcvac-luca-d... | SOTIO to Present Final Phase I/II DCVAC/LuCa Data at ASCO 2019 Annual Meeting |
/201905171929/cristal-therapeutics-to-present-data-at-the-am... | Cristal Therapeutics to Present Data at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting on Lead Clinical Ca... |
/201905151928/probiogen-and-vaccitech-sign-license-agreement... | ProBioGen and Vaccitech Sign License Agreement for ProBioGen’s Technology Platform |
/201905141927/sensid-inks-distribution-agreement-with-tataa-... | SensID Inks Distribution Agreement with TATAA Biocenter for its MDx Reference Standards |
/201905091926/new-ultra-convenient-solid-phase-extraction-di... | New Ultra Convenient Solid Phase Extraction Disks from Biotage |
/201905081925/sartorius-stedim-biotech-introduces-new-simca-... | Sartorius Stedim Biotech Introduces New SIMCA® 16 Software for Multivariate Data Analytics |
/201905071924/esact-inaugural-innovation-award-to-honor-prob... | ESACT Inaugural Innovation Award to Honor ProBioGen’s CSO Dr. Volker Sandig |
/201905071923/wise-enrols-first-patient-in-pivotal-clinical-... | WISE Enrols First Patient in Pivotal Clinical Study of Novel Neuro-Electrodes for Brain Monitoring |
/201905021922/sartorius-stedim-biotech-launches-new-ambr-15-... | Sartorius Stedim Biotech Launches New ambr® 15 Cell Culture Microbioreactor System |
/201905021921/amal-therapeutics-enters-clinical-collaboratio... | AMAL Therapeutics Enters Clinical Collaboration with Boehringer Ingelheim to Evaluate ATP128 in Combination with BI754091 |
/201904291920/implandata-successfully-gains-ce-mark-for-its-... | Implandata Successfully Gains CE Mark for its EYEMATE System for an Orphan Eye Indication |
/201904251919/shuwen-presents-at-the-2nd-companion-diagnosti... | Shuwen Presents at The 2nd Companion Diagnostic & I-O Biomarker Conference in Shanghai |
/201904241918/new-data-show-blueprint-identifies-estrogen-re... | New Data Show BluePrint® Identifies Estrogen Receptor Positive Breast Cancer Patients with Poor Response to Anti-Estrogen Therap... |
/201904241917/velabs-therapeutics-to-cooperate-with-chiome-b... | Velabs Therapeutics to Cooperate with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening |
/201904161916/vetter-s-skokie-facility-expansion-nears-compl... | Vetter's Skokie Facility Expansion Nears Completion |
/201903281915/novel-first-in-class-flip-inhibitors-for-the-t... | Novel First-In-Class FLIP Inhibitors for the Treatment of Cancer |
/201903281914/proteonic-biotechnology-licenses-protein-produ... | ProteoNic Biotechnology Licenses Protein Production Technology to Bayer |
/201903281913/bcg-digital-ventures-and-sartorius-help-launch... | BCG Digital Ventures and Sartorius Help Launch the World’s First Voice-Powered Digital Assistant for Scientists |
/201903281912/tasly-pharmaceutical-group-taps-shuwen-biotech... | Tasly Pharmaceutical Group Taps Shuwen Biotech for Companion Diagnostic Services |
/201903271911/ambr-15-fermentation-and-ambr-250-high-through... | ambr® 15 Fermentation and ambr® 250 High Throughput Systems Now Available with Integrated Online Biomass Measurement for Microbi... |
/201903261910/eur-3-million-in-series-a-for-the-growth-and-d... | EUR 3 Million in Series A for the Growth and Development of Cytena GmbH |
/201903251909/implandata-successfully-gains-ce-mark-for-next... | Implandata Successfully Gains CE Mark for Next-Generation EyeMate System and Poised for European-Wide Market Launch |
/201903221908/alzprotect-starts-collaboration-with-parexel-b... | AlzProtect Starts Collaboration with PAREXEL Biotech for Phase 2a of AZP2006 for the Treatment of Progressive Supranuclear Palsy... |
/201903211907/customers-experience-leads-to-a-highly-success... | Customers’ Experience Leads to a Highly Successful Outcome for Vetter at the 2019 CMO Leadership Awards |
/201903211906/ab2-bio-announces-readiness-for-recruitment-in... | AB2 Bio Announces Readiness for Recruitment in Pivotal Phase 3 Trial of Tadekinig Alfa, a Novel Human Recombinant Interleukin-18... |
/201903211905/lead-pharma-announces-start-of-phase-i-clinica... | Lead Pharma Announces Start of Phase I Clinical Trials with SAR441169 Candidate Treatment for Psoriasis |
/201903201904/domainex-and-spirochem-enter-a-fragment-drug-d... | Domainex and SpiroChem Enter a Fragment Drug Discovery Partnership |
/201903191903/sotio-s-dcvac-ovca-significantly-improves-surv... | SOTIO’s DCVAC/OvCa Significantly Improves Survival in Patients with Recurrent Ovarian Cancer |
/201903181902/cellesce-announces-license-agreement-with-hubr... | Cellesce Announces License Agreement with Hubrecht Organoid Technology (HUB) for the Expansion of Breast Cancer Organoids at Sca... |
/201903131901/deuterium-depletion-is-a-disruptive-innovation... | Deuterium Depletion is a Disruptive Innovation in the Pharma Industry - HYD Pharma Develops New Deuterium-Depleted Drugs for the... |
/201903131900/nbe-to-present-late-breaking-abstract-on-lead-... | NBE to Present Late-Breaking Abstract on Lead ADC Program NBE-002 (ROR1) at the AACR Annual Meeting |
/201903081899/third-sartorius-research-xchange-forum-2019-fo... | Third Sartorius Research Xchange Forum 2019 Focuses on CAR-T Cell Therapy |
/201903071898/potential-new-treatment-for-heart-attack.html | Potential New Treatment for Heart Attack |
/201903071897/sotio-to-present-final-phase-ii-dcvac-ovca-dat... | SOTIO to Present Final Phase II DCVAC/OvCa Data at the 2019 SGO Annual Meeting on Women's Cancer |
/201903051896/adult-stem-cell-derived-kidney-on-a-chip-in-na... | Adult Stem Cell-Derived Kidney-on-a-Chip in Nature Biotechnology |
/201903051895/sartorius-stedim-biotech-and-novasep-to-develo... | Sartorius Stedim Biotech and Novasep to Develop Novel Systems for Membrane Chromatography |
/201903041894/novago-therapeutics-raises-chf-10-million-to-d... | NovaGo Therapeutics Raises CHF 10 Million to Develop Regenerative Anti-Nogo Therapy for Stroke |
/201903011893/neurimmune-appoints-john-dellapa-as-general-co... | Neurimmune Appoints John Dellapa as General Counsel |
/201902281892/confo-therapeutics-forms-scientific-advisory-b... | Confo Therapeutics Forms Scientific Advisory Board as It Accelerates Development of Proprietary Drug Discovery Engine |
/201902271891/cac-and-rfxcel-announce-a-partnership-agreemen... | CAC and rfxcel Announce a Partnership Agreement for Pharmaceutical Traceability |
/201902201890/sapreme-technologies-in-a-6-8-m-eu-alliance-to... | Sapreme Technologies in a 6.8 M€ EU Alliance to Develop an Oligonucleotide Delivery Platform Based on Its Proprietary Endosomal ... |
/201902201889/calypso-biotech-bv-secures-20-million-eur-in-s... | Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody ... |
/201902201888/alzprotect-on-track-for-a-phase-2-entry-in-201... | AlzProtect, on Track for a Phase 2 Entry in 2019, for its Drug Candidate AZP2006 |
/201902191887/rsp-systems-to-exhibit-its-cutting-edge-non-in... | RSP Systems to Exhibit Its Cutting-Edge Non-Invasive Glucose Monitor, GlucoBeam at ATTD 2019 |
/201902131886/haselmeier-acquires-drug-manufacturing-license... | Haselmeier Acquires Drug Manufacturing License and Now Offers Assembly, Labelling and Packaging Services to Pharmaceutical and... |
/201902081885/andrew-alliance-and-sartorius-collaborate-to-p... | Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research |
/201902071884/cellmid-significant-new-findings-published-on-... | Cellmid: Significant New Findings Published on Midkine |
/201902051883/audion-therapeutics-and-regain-consortium-anno... | Audion Therapeutics and REGAIN Consortium Announce Positive Phase I Results in Patients with Sensorineural Hearing Loss |
/201902051882/sotio-appoints-dr-harald-fricke-as-chief-medic... | SOTIO Appoints Dr. Harald Fricke as Chief Medical Officer |
/201902051881/proteonic-biotechnology-licenses-protein-produ... | ProteoNic Biotechnology Licenses Protein Production Technology to Eli Lilly and Company |
/201901311880/sartorius-joins-the-community-of-the-national-... | Sartorius Joins the Community of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) |
/201901311878/hitachi-chemical-co-ltd-to-acquire-apceth-biop... | Hitachi Chemical Co. Ltd. to Acquire apceth Biopharma GmbH |
/201901241877/new-combined-diagnostic-and-antimicrobial-susc... | New Combined Diagnostic and Antimicrobial Susceptibility Test Enables Resistance-Guided Therapy for Gonorrhoea |
/201901231876/sartorius-stedim-biotech-offers-services-for-c... | Sartorius Stedim Biotech Offers Services for Characterization of New Biological Entities (NBE) |
/201901221874/crispr-therapeutics-and-probiogen-sign-collabo... | CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies |
/201901221875/orchard-announces-publication-by-san-raffaele-... | Orchard Announces Publication by San Raffaele-Telethon Institute for Gene Therapy of OTL-300 Clinical Data for the Treatment of ... |
/201901211873/sartorius-stedim-biotech-introduces-biostat-rm... | Sartorius Stedim Biotech Introduces BIOSTAT® RM TX with Flexsafe® RM TX for Producing Consistent Quality Cellular Products |
/201901211872/minervax-announces-award-of-4-4-million-euro-i... | MinervaX Announces Award of 4.4 Million Euro in Investment from Novo Holdings REPAIR Impact Fund and Sunstone Capital for Furthe... |
/201901101871/toxys-appoints-four-new-board-members-to-accel... | Toxys Appoints Four New Board Members to Accelerate Business Growth |
/201901101870/clinigen-extends-exclusive-european-clinical-t... | Clinigen Extends Exclusive European Clinical Trial Sourcing and Supply Agreement with Accord Healthcare |
/201901071869/orchard-therapeutics-highlights-recent-accompl... | Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy |
/201901071868/velabs-therapeutics-to-cooperate-with-biomed-x... | Velabs Therapeutics to Cooperate with BioMed X in the Field of Immunology |
/201812141867/orchard-therapeutics-and-sirion-biotech-announ... | Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency |
/201812141866/prestige-biopharma-partners-with-cipla-ltd-to-... | Prestige BioPharma Partners with Cipla Ltd to Market Key Cancer Biosimilar |
/201812131865/orchard-therapeutics-announces-the-build-out-o... | Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California |
/201812111864/batavia-biosciences-partners-with-iavi-to-adva... | Batavia Biosciences Partners with IAVI to Advance Development of Vaccine Against Lassa Fever |
/201812071863/orchard-therapeutics-appoints-industry-veteran... | Orchard Therapeutics Appoints Industry Veteran Alicia Secor to its Board of Directors |
/201812071862/shuwen-biotech-wins-at-the-7th-annual-china-in... | Shuwen Biotech Wins at the 7th Annual China Innovation and Entrepreneurship Competition |
/201812051861/donald-b-kohn-md-orchard-therapeutics-scientif... | Donald B. Kohn, MD, Orchard Therapeutics Scientific Advisory Board Member, Presents Clinical Proof-of-Concept Data for OTL-102 G... |
/201812041860/dr-irina-buhimschi-joins-shuwen-biotech-as-a-s... | Dr. Irina Buhimschi Joins Shuwen Biotech as a Scientific Advisor |
/201812031859/first-patient-successfully-implanted-with-impl... | First Patient Successfully Implanted with Implandata’s Novel Eye Pressure Sensor for Continual Glaucoma Monitoring |
/201811281858/biontech-mammatyper-validated-as-predictor-for... | BioNTech: MammaTyper® Validated as Predictor for Response After Neoadjuvant Chemotherapy (NACT) in Patients with Early Breast Ca... |
/201811261857/immune-regulation-announces-positive-results-f... | Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN201104 |
/201811211856/selvita-announces-presentations-on-cdk8-inhibi... | Selvita Announces Presentations on CDK8 Inhibitor SEL120 at the 60th American Society of Hematology Annual Meeting |
/201811191855/restoring-sight-clinical-progress-towards-aust... | Restoring Sight: Clinical Progress Towards Australia’s Bionic Eye |
/201811161854/elpis-biomed-wins-cambridge-start-up-of-the-ye... | Elpis Biomed Wins Cambridge Start-Up of the Year |
/201811151853/dr-anthony-tolcher-joins-the-scientific-adviso... | Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE-Therapeutics |
/201811141852/top-oncologist-dr-samuel-fourie-joins-advisory... | Top Oncologist, Dr Samuel Fourie, Joins Advisory Board of AzarGen Biotechnologies |
/201811121851/amal-therapeutics-finalises-29-million-chf-33-... | AMAL Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round |
/201811121850/retipharma-secures-funding-to-develop-treatmen... | RetiPharma Secures Funding to Develop Treatments of Degenerative Eye Disorders |
/201811091848/icosabutate-latest-data-shows-direct-and-poten... | Icosabutate Latest Data Shows Direct and Potent Anti-Fibrotic Effect in Both Differentiated Rodent NASH Models and Human Stellat... |
/201811091849/t3-pharmaceuticals-wins-prestigious-falling-wa... | T3 Pharmaceuticals Wins Prestigious Falling Walls Venture Award for Its Bacterial Cancer Therapy |
/201811081847/selvita-to-present-new-data-from-sel120-progra... | Selvita to Present New Data from SEL120 Program at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
/201811081846/orchard-therapeutics-strengthens-global-commer... | Orchard Therapeutics Strengthens Global Commercial Leadership Team with Appointments of Heads of US and EMEA Region Commercial O... |
/201811061845/probiogen-announces-successful-bispecific-glym... | ProBioGen Announces Successful Bispecific GlymaxX® Development Project for Zymeworks |
/201811051844/orchard-therapeutics-announces-closing-of-225-... | Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters' ... |
/201810311843/selvita-to-present-new-data-from-its-oncology-... | Selvita to Present New Data from its Oncology Programs at the Upcoming SITC 2018 |
/201810311842/orchard-therapeutics-announces-pricing-of-init... | Orchard Therapeutics Announces Pricing of Initial Public Offering |
/201810251841/elpis-biomed-human-cell-models-could-potential... | Elpis Biomed Human Cell Models Could Potentially Replace Animal Experiments in Drug Discovery |
/201810251840/cristal-therapeutics-initiates-phase-2-clinica... | Cristal Therapeutics Initiates Phase 2 Clinical Trial of Innovative CriPec® Nanomedicine Drug Candidate in Ovarian Cancer |
/201810241839/vetter-further-expands-secondary-packaging.htm... | Vetter Further Expands Secondary Packaging |
/201810221838/change-of-company-name-vtu-technology-is-now-v... | Change of Company Name: VTU Technology is now VALIDOGEN |
/201810221837/polyganics-initiates-first-in-human-trial-of-l... | Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure |
/201810191836/apceth-biopharma-presents-positive-data-demons... | apceth Biopharma Presents Positive Data Demonstrating Efficacy of apceth-201 in Preclinial Models of Acute GvHD |
/201810111835/ime-medical-electrospinning-enters-into-develo... | IME Medical Electrospinning Enters into Development Cooperation with Leading Chinese Medical Devices Company Amor Medical |
/201810111834/not-just-for-pharma-anymore-rfxcel-extends-tra... | Not Just for Pharma Anymore: rfxcel Extends Track & Trace Solutions to Food & Beverage |
/201810081833/tfs-collaboration-with-lobsor-pharmaceuticals-... | TFS Collaboration with Lobsor Pharmaceuticals AB, on the Development of Lecigon®, Has Resulted in Marketing Authorization of Lec... |
/201810051832/apceth-to-manufacture-first-potential-one-time... | apceth to Manufacture First Potential One-Time Gene Therapy for Transfusion-Dependent Beta-Thalassemia |
/201810041831/orchard-therapeutics-receives-ema-prime-design... | Orchard Therapeutics Receives EMA PRIME Designation for OTL-300, an Investigational Lentiviral Gene Therapy for the Treatment of... |
/201810041830/metp-pharma-introduces-nascum-plus-against-the... | MetP® Pharma Introduces Nascum®-Plus Against the Onset of Air Pollution-induced Inflammation |
/201810011829/new-flash-purification-system-and-columns-from... | New Flash Purification System and Columns from Biotage |
/201809261828/vetter-grants-award-for-novel-idea-at-the-open... | Vetter Grants Award for Novel Idea at the Open Innovation Challenge – Injection 2.0 |
/201809261827/transplantation-medicine-c-cit-sensors-to-prov... | Transplantation Medicine: C-CIT Sensors to Provide Biosensors for Ex Vivo Liver Perfusion Machine of Wyss Zurich Project Liver4L... |
/201809201826/medtech-company-ime-medical-electrospinning-es... | Medtech Company IME Medical Electrospinning Establishes New High-Tech Production Facility to Set The World Wide Standard for Gro... |
/201809181825/dominick-arena-joins-implandata-ophthalmic-pro... | Dominick Arena Joins Implandata Ophthalmic Products GmbH Board of Directors as Chairman |
/201809181824/neurimmune-achieves-milestone-in-collaboration... | Neurimmune Achieves Milestone in Collaboration with Ono Pharmaceutical |
/201809171823/shuwen-biotech-s-pd-l1-detection-kit-validated... | Shuwen Biotech‘s PD-L1 Detection Kit Validated in Clinical Trials of Leading Drugs |
/201809101822/rsp-systems-adds-eur-3-85-million-in-a-second-... | RSP Systems Adds EUR 3,85 Million in a Second Closing of its Series B Funding Round, Increasing the Round Total to EUR 10,35 Mil... |
/201809091821/menarini-will-bring-lunaphore-s-ultra-rapid-ti... | Menarini Will Bring Lunaphore’s Ultra-Rapid Tissue Staining Solution LabSat™ Frozen to Market |
/201809051820/thrombolytic-science-initiates-phase-2-clinica... | Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke |
/201809041819/sartorius-stedim-biotech-and-repligen-corporat... | Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors |
/201808301818/sotio-and-ppf-complete-acquisition-of-cytune-p... | SOTIO and PPF Complete Acquisition of Cytune Pharma |
/201808291817/orchard-therapeutics-expands-leadership-team-w... | Orchard Therapeutics Expands Leadership Team with Appointments of Head of Corporate Communications and Head of Human Resources |
/201808201816/c-cit-sensors-single-use-cell-culture-in-situ-... | C-CIT Sensors: Single-use Cell Culture In-situ Technologies for the Simultaneous Automated and Continuous Monitoring of Glucose ... |
/201808161815/rfxcel-enhances-pharmaceutical-track-and-trace... | rfxcel Enhances Pharmaceutical Track and Trace Solution for Russia |
/201808131814/orchard-therapeutics-announces-150-million-ser... | Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline |
/201808071813/rsp-systems-is-awarded-the-iso-13485-2016-cert... | RSP Systems is Awarded the ISO 13485:2016 Certification from LRQA, an Important Milestone Towards CE Marking and Product Launch |
/201808021812/orchard-therapeutics-appoints-jon-ellis-to-boa... | Orchard Therapeutics Appoints Jon Ellis to Board of Directors |
/201808021811/turkish-pharmaceutical-industry-leader-abdi-ib... | Turkish Pharmaceutical Industry Leader, Abdi Ibrahim, Selects rfxcel for FMD Compliance |
/201807231810/azafaros-b-v-secures-seed-funding-to-develop-n... | Azafaros B.V. Secures Seed Funding to Develop New Treatments in Rare Metabolic Disorders |
/201807191809/kite-and-gadeta-announce-strategic-collaborati... | Kite and Gadeta Announce Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors |
/201807191808/shuwen-biotech-s-clinical-lab-successfully-pas... | Shuwen Biotech's Clinical Lab Successfully Passes Biyearly College of American Pathologists Audit |
/201807171807/polares-medical-closes-a-25m-financing-to-ente... | Polares Medical Closes a $25M Financing to Enter Clinical Validation |
/201807171806/leon-nanodrugs-supports-takeda-in-a-feasibilit... | leon-nanodrugs Supports Takeda in a Feasibility Assessment of leon’s Proprietary MicroJet Reactor (MJR®) Nano-Technology |
/201807121805/antabio-completes-12-5m-series-a.html | ANTABIO Completes € 12.5M Series A |
/201807121804/immatics-enters-into-a-strategic-partnership-w... | Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies |
/201807101803/probiogen-and-pionyr-immunotherapeutics-initia... | ProBioGen and Pionyr Immunotherapeutics Initiate a Second Immuno-oncology Contract Development and Manufacturing Project |
/201807091802/orchard-therapeutics-appoints-joanne-beck-ph-d... | Orchard Therapeutics Appoints Joanne Beck, Ph.D. to Board of Directors |
/201807021801/varmx-raises-12-5-million-to-develop-modified-... | VarmX Raises € 12.5 Million to Develop Modified Blood Coagulation Factor X for Treating Severe Bleeding in Patients Using Anti-C... |
/201807021800/abcam-merck-collaboration-produces-new-pd-l1-a... | Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research |
/201806291799/aptamer-group-uk-biotech-business-raises-2-2m-... | Aptamer Group: UK Biotech Business Raises $2.2M Investment |
/201806291798/orchard-therapeutics-appoints-jim-geraghty-as-... | Orchard Therapeutics Appoints Jim Geraghty as Chairman of its Board of Directors |
/201806281797/prestige-biopharma-and-alvogen-announce-licens... | Prestige Biopharma and Alvogen Announce License and Supply Agreement to Commercialize Prestige´s Trastuzumab Biosimilar (Hervelo... |
/201806281796/nbe-therapeutics-closes-a-chf-20-million-finan... | NBE Therapeutics Closes a CHF 20 Million Financing by Novo Holdings A/S |
/201806271795/mdxhealth-s-selectmdx-test-successfully-strati... | MDxHealth's SelectMDx Test Successfully Stratifies Men Who May Benefit from mp-MRI for Prostate Cancer Diagnosis |
/201806261794/reapplix-positive-outcome-data-of-large-random... | Reapplix: Positive Outcome Data of Large Randomized Controlled Trial Presented at American Diabetes Association Scientific Sessi... |
/201806261793/probiogen-and-nouscom-sign-license-agreement-f... | ProBioGen and Nouscom Sign License Agreement for ProBioGen’s Technology Platform |
/201806261792/inthera-bioscience-ag-expands-management-team-... | Inthera Bioscience AG Expands Management Team with Seasoned Professionals and Secures €4.7 Million Second Tranche of €9.6 Millio... |
/201806211791/cellgenix-completed-first-step-of-facility-exp... | CellGenix Completed First Step of Facility Expansion to Stay on Top of the Increasing Demands for GMP Cell Culture Reagents |
/201806201790/tfs-international-appoints-dr-suzanne-pavon-as... | TFS International Appoints Dr Suzanne Pavon as Executive Vice President, Quality Assurance |
/201806191789/neural-analytics-inc-receives-ce-mark-for-its-... | Neural Analytics, Inc. Receives CE Mark for its Robotic Ultrasound System |
/201806151788/triple-digit-growth-in-emea-as-pharma-companie... | Triple Digit Growth in EMEA as Pharma Companies Embrace rfxcel’s Full-Service Approach to FMD Compliance |
/201806141787/clinigen-signs-exclusive-supply-distribution-a... | Clinigen Signs Exclusive Supply & Distribution Agreement with Lukare for Elliotts B® Solution |
/201806121786/sartorius-stedim-biotech-and-siemens-sign-long... | Sartorius Stedim Biotech and Siemens Sign Long-Term Cooperation Agreement in the Area of Automation |
/201806111785/rsp-systems-secures-series-b-funding-to-drive-... | RSP Systems Secures Series B Funding to Drive its Non-Invasive Glucose Monitor |
/201806071784/vetter-strikes-out-on-new-pathways-to-further-... | Vetter Strikes Out on New Pathways to Further Develop the Injection Process |
/201806071783/orchard-therapeutics-announces-appointments-of... | Orchard Therapeutics Announces Appointments of Marc Dunoyer and Charlie Rowland to Board of Directors |
/201806031782/phase-ii-clinical-trials-of-dcvac-show-signifi... | Phase II Clinical Trials of DCVAC Show Significant Benefit for Patients with Ovarian and Lung Cancer |
/201806011781/biotheranostics-announces-presentation-of-key-... | Biotheranostics Announces Presentation of Key Data for CancerTYPE ID® and Breast Cancer Index™ at ASCO Annual Meeting in Chicago |
/201806011780/ppd-and-neogenomics-forming-global-strategic-a... | PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions |
/201805311779/thrombolytic-science-to-participate-in-2018-bi... | Thrombolytic Science to Participate in 2018 BIO International Conference |
/201805301778/zai-lab-and-crescendo-biologics-enter-exclusiv... | Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory... |
/201805281777/shuwen-biotech-and-bliss-biopharmaceutical-par... | Shuwen Biotech and Bliss Biopharmaceutical Partner on Companion Diagnostics for Cancer Drugs |
/201805241776/probiogen-announces-further-development-milest... | ProBioGen Announces Further Development Milestone for Use of Its GlymaxX® Cancer Cell-Killing Enhancement Antibody Technology wi... |
/201805241775/thrombolytic-science-to-present-at-the-15th-an... | Thrombolytic Science to Present at the 15th Anglo Nordic Life Science Investor Conference |
/201805241774/sotio-starts-phase-i-ii-trial-of-dcvac-in-comb... | SOTIO Starts Phase I/II Trial of DCVAC in Combination with ONCOS-102: The Targovax Adenovirus Based Immunotherapy |
/201805241773/lunaphore-and-vitro-sign-collaboration-agreeme... | Lunaphore and Vitro Sign Collaboration Agreement to Develop ISH Protocols for RNA/DNA Targets |
/201805241772/agendia-and-angsana-to-provide-breast-cancer-r... | Agendia and Angsana to Provide Breast Cancer Risk-of-Recurrence Testing with MammaPrint® and BluePrint® to Patients in Southeast... |
/201805231771/rfxcel-covers-the-cost-of-emvo-onboarding-fees... | rfxcel Covers the Cost of EMVO Onboarding Fees |
/201805231770/peptide-display-company-orbit-discovery-closes... | Peptide Display Company Orbit Discovery Closes £6.9M Series A Financing |
/201805221769/clinigen-and-mitsubishi-tanabe-initiate-europe... | Clinigen and Mitsubishi Tanabe Initiate European Managed Access Program for Edaravone to Treat ALS |
/201805171768/shuwen-debuts-it-s-codar-arms-pcr-liquid-biops... | Shuwen Debuts it's CODAR-ARMS PCR Liquid Biopsy Technology at ASCO 2018 |
/201805151767/new-insights-into-hookipa-s-therat-replicating... | New Insights into Hookipa’s TheraT® Replicating Viral Vector Platform Published in Immunity |
/201805151766/agendia-s-mammaprint-and-blueprint-breast-canc... | Agendia’s MammaPrint® and BluePrint® Breast Cancer Tests Selected by Unicancer for French Patients |
/201805141765/successful-first-series-c-round-closing-for-me... | Successful First Series C-Round Closing for Medical Device Company Implandata Ophthalmic Products GmbH |
/201805141764/emergex-awarded-innovate-uk-grant-to-progress-... | Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu Vaccine |
/201805101763/new-uv-monitor-kit-for-large-scale-purificatio... | New UV Monitor Kit for Large Scale Purification |
/201805081762/celonic-ag-appoints-soenke-brunswieck-as-vice-... | Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy |
/201805071761/abcam-and-shuwen-biotech-sign-strategic-mou-to... | Abcam and Shuwen Biotech Sign Strategic MoU to Establish Global Alliance for Companion Diagnostic (CDx) Kit Development |
/201805041760/the-swiss-biotech-association-honors-major-ind... | The Swiss Biotech Association Honors Major Industry Achievements with Swiss Biotech Success Stories |
/201805031759/haselmeier-and-common-sensing-enter-connected-... | Haselmeier and Common Sensing Enter Connected Injectable Medicine Collaboration |
/201805031758/orchard-therapeutics-otl-200-receives-rare-ped... | Orchard Therapeutics’ OTL-200 Receives Rare Pediatric Disease Designation from FDA for Treatment of Metachromatic Leukodystrophy |
/201805011757/biogen-and-neurimmune-announce-option-exercise... | Biogen and Neurimmune Announce Option Exercise for Alzheimer’s Disease Investigational Treatment Aducanumab |
/201804261756/neurimmune-appoints-fabian-buller-as-chief-bus... | Neurimmune Appoints Fabian Buller as Chief Business Officer |
/201804241754/orchard-therapeutics-expands-us-presence-with-... | Orchard Therapeutics Expands US Presence with New Corporate Office in Boston |
/201804241755/rapid-detection-of-pathogen-and-antibiotic-res... | Rapid Detection of Pathogen and Antibiotic Resistance with DNAe’s LiDia® Bloodstream Infection (BSI) Technology |
/201804201753/sartorius-stedim-biotech-introduces-mini-micro... | Sartorius Stedim Biotech Introduces Mini Microcarrier Bioreactor for Culturing Adherent Cells |
/201804181752/probiogen-signs-second-contract-development-ag... | ProBioGen Signs Second Contract Development Agreement with Tizona Therapeutics for Immuno-Oncology Antibody Project |
/201804171751/vetter-welcomes-illinois-governor-bruce-rauner... | Vetter Welcomes Illinois Governor Bruce Rauner to its German Facilities |
/201804171750/wacker-strengthens-its-pharmaceutical-protein-... | WACKER Strengthens Its Pharmaceutical-Protein Business and Buys Dutch Biotechnology Plant |
/201804161749/sartorius-stedim-biotech-and-penn-state-univer... | Sartorius Stedim Biotech and Penn State University Announce Partnership |
/201804131748/oncology-company-hercules-pharmaceuticals-to-p... | Oncology Company Hercules Pharmaceuticals to Present AhR Inhibitor Efficacy Results at Upcoming AACR Meeting on Monday April 16 |
/201804131747/dnae-to-present-new-data-and-preview-its-blood... | DNAe to Present New Data and Preview its Blood-to-Result Test for Bloodstream Infection at ECCMID 2018 |
/201804121746/potential-of-icosabutate-as-a-novel-approach-t... | Potential of Icosabutate as a Novel Approach to the Treatment of NASH Highlighted in Late-Breaker At The International Liver Con... |
/201804121745/gsk-signs-strategic-agreement-to-transfer-rare... | GSK Signs Strategic Agreement to Transfer Rare Disease Gene Therapy Portfolio to Orchard Therapeutics |
/201804111744/aurigene-to-present-multiple-programs-at-the-a... | Aurigene to Present Multiple Programs at the AACR 2018 In Chicago, Illinois: (A) Novel Small Molecule, Oral, Antagonists of CD47... |
/201804111743/mimetas-secures-20-million-dollar-series-b-fin... | MIMETAS Secures 20 Million Dollar Series B Financing |
/201804061742/selvita-to-present-new-data-from-its-oncology-... | Selvita to Present New Data from Its Oncology Programs at the Upcoming AACR Annual Meeting 2018 |
/201804041741/tfs-international-to-strengthen-strategic-plan... | TFS International to Strengthen Strategic Planning Capabilities with Citeline Deal |
/201804031740/tfs-international-appoints-dr-andrew-copestake... | TFS International Appoints Dr Andrew Copestake as Chief Commercial Officer |
/201803231739/new-real-world-clinical-practice-data-reinforc... | New Real-World Clinical Practice Data Reinforces the Value of the Oncotype DX Breast Recurrence Score® Test for Patients, Physic... |
/201803231738/medtech-company-ime-technologies-moves-to-new-... | Medtech Company IME Technologies Moves to New and Much Larger R & D And Production Facility in Waalre, The Netherlands |
/201803211737/vetter-wins-2018-ipse-facility-of-the-year-awa... | Vetter Wins 2018 ISPE Facility of the Year Award |
/201803211735/agendia-announces-ce-mark-for-ngs-based-mammap... | Agendia Announces CE Mark for NGS-Based MammaPrint® BluePrint® Kit Enhancing Access to Personalized Treatment for Breast Cancer ... |
/201803211734/orchard-therapeutics-strengthens-executive-lea... | Orchard Therapeutics Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer and General Counsel |
/201803161733/sartorius-stedim-biotech-supports-abl-europe-i... | Sartorius Stedim Biotech Supports ABL Europe in Successful Completion of Viral Vector GMP Capacity Expansion |
/201803141732/sartorius-stedim-biotech-launches-new-ambr-250... | Sartorius Stedim Biotech Launches New ambr® 250 High Throughput Bioreactor System for Perfusion Culture |
/201803091731/orchard-therapeutics-scientific-founder-prof-d... | Orchard Therapeutics Scientific Founder Prof Donald Kohn Recognized with Pediatric Blood and Marrow Transplant Consortium Lifeti... |
/201803081730/probiogen-and-surface-oncology-sign-second-ant... | ProBioGen and Surface Oncology Sign Second Antibody Manufacturing Program |
/201803061729/orchard-therapeutics-to-present-at-the-cowen-a... | Orchard Therapeutics to Present at the Cowen and Company Annual Healthcare Conference |
/201803021728/judith-heikoop-appointed-managing-director-at-... | Judith Heikoop Appointed Managing Director at Biomedical Electro Spinning Company IME Technologies |
/201802281727/project-pharmaceutics-expands-facilities-for-f... | ProJect Pharmaceutics Expands Facilities for Formulation and Lyophilization Process Development to Meet Safety Requirements for ... |
/201802271726/biopharmaspec-launches-new-host-cell-protein-d... | BioPharmaSpec Launches New Host Cell Protein Detection Service |
/201802211725/serious-about-serialisation-dcc-vital-selects-... | Serious About Serialisation: DCC Vital Selects rfxcel for EU FMD Compliance |
/201802161724/selvita-announces-successful-completion-of-41-... | Selvita Announces Successful Completion of $41 M Book Building |
/201802151723/vetter-is-a-winner-of-the-fraunhofer-clean-man... | Vetter Is a Winner of the Fraunhofer Clean Manufacturing Award CLEAN! 2018 |
/201802131721/orchard-therapeutics-to-present-at-the-rbc-cap... | Orchard Therapeutics to Present at the RBC Capital Markets 2018 Global Healthcare Conference |
/201802131722/new-isolute-hydro-dme-rapidly-removes-matrix-i... | New ISOLUTE® HYDRO DME+ Rapidly Removes Matrix Interferences from Urine |
/201802071720/probiogen-and-teva-sign-license-agreement-on-h... | ProBioGen and TEVA Sign License Agreement on Human Artificial Lymph Node Technology |
/201802061719/selvita-appoints-steffen-heeger-m-d-phd-as-chi... | Selvita Appoints Steffen Heeger, M.D., PhD as Chief Medical Officer |
/201802051718/orchard-therapeutics-appoints-dr-harry-malech-... | Orchard Therapeutics Appoints Dr. Harry Malech to Scientific Advisory Board |
/201802021717/vetter-introduces-south-korea-s-pharma-and-bio... | Vetter Introduces South Korea’s Pharma and Biotech Community to Meet Company Management |
/201801291715/zz-biotech-announces-preliminary-phase-2-strok... | ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results with 3K3A-APC |
/201801251714/araclon-biotech-partners-with-tfs-internationa... | Araclon Biotech Partners with TFS International for Their Alzheimer’s Phase II Trial |
/201801171713/futuragene-s-exclusive-license-for-rnai-techno... | FuturaGene's Exclusive License for RNAi Technology in Eucalyptus Enhanced by Grant of Patent in Brazil |
/201801171712/orchard-therapeutics-appoints-frank-thomas-as-... | Orchard Therapeutics Appoints Frank Thomas as Chief Financial Officer and Chief Business Officer |
/201801161711/batavia-biosciences-teams-up-with-internationa... | Batavia Biosciences Teams Up with International Consortium to Support Polio Eradication |
/201801151710/biontech-announces-results-from-two-more-studi... | BioNTech Announces Results from Two More Studies Demonstrating the Benefits of Breast Cancer Subtyping Using Mammatyper® |
/201801101709/tfs-international-appoints-new-chief-executive... | TFS International Appoints New Chief Executive Officer |
/201801091708/wacker-obtains-fda-approval-to-manufacture-the... | WACKER Obtains FDA Approval to Manufacture the Drug Substance in Retavase®, a Thrombolysis Medication by Chiesi |
/201801051707/antabio-announces-key-executive-appointments.h... | ANTABIO Announces Key Executive Appointments |
/201801041706/abzena-selects-sartorius-stedim-biotech-to-equ... | Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites in San Diego and Bristol |
/201712221705/orchard-therapeutics-to-present-at-the-36th-an... | Orchard Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference |
/201712211704/rfxcel-approved-as-a-technically-certified-con... | rfxcel Approved as a Technically Certified Connection Provider for EMVO |
/201712201703/orchard-therapeutics-announces-110m-series-b-f... | Orchard Therapeutics Announces $110M Series B Financing to Advance Transformative Gene Therapy Pipeline |
/201712191702/agendia-and-bluebee-partner-to-bring-new-ngs-b... | Agendia and Bluebee Partner to Bring New NGS-Based MammaPrint® BluePrint® Breast Cancer Kit to Market |
/201712151701/orchard-therapeutics-and-genethon-announce-gen... | Orchard Therapeutics and Généthon Announce Gene Therapy Alliance in X-linked Chronic Granulomatous Disease |
/201712141700/fda-grants-orphan-drug-designation-to-zytoprot... | FDA Grants Orphan Drug Designation to Zytoprotec's Novel Dialysis Fluid |
/201712141699/thrombolytic-science-announces-the-appointment... | Thrombolytic Science Announces the Appointment of Annalisa Jenkins, MBBS, FRCP, as a Non-Executive Board Member |
/201712131698/key-executives-join-the-rfxcel-team-to-drive-g... | Key Executives Join the rfxcel Team to Drive Global Growth |
/201712121697/agendia-key-studies-presented-at-the-san-anton... | Agendia: Key Studies Presented at the San Antonio Breast Cancer Symposium Demonstrate the Important Role of MammaPrint® for Pati... |
/201712121696/dr-hitto-kaufmann-of-sanofi-aventis-and-dr-eli... | Dr. Hitto Kaufmann of Sanofi-Aventis and Dr. Eliana Clark of Biogen to Deliver Plenary Keynote Presentations at CHI’s Bioprocess... |
/201712121695/biogenes-establishes-scientific-advisory-board... | BioGenes Establishes Scientific Advisory Board |
/201712121694/northsea-therapeutics-secures-25-million-fundi... | NorthSea Therapeutics Secures €25 Million Funding for Clinical Development of Promising NASH Drug |
/201712111693/genomic-health-new-validation-shows-oncotype-d... | Genomic Health: New Validation Shows Oncotype DX Breast Recurrence Score® Test Predicts Clinical Response to Neoadjuvant Hormona... |
/201712071692/sartorius-stedim-biotech-launches-new-versions... | Sartorius Stedim Biotech Launches New Versions of Data Analytics Software Solutions |
/201712071691/agendia-and-uz-leuven-partner-to-co-validate-m... | Agendia and UZ Leuven Partner to Co-Validate MammaPrint® BluePrint® Breast Cancer Risk of Recurrence and Molecular Subtyping Kit... |
/201712061690/vetter-receives-corporate-health-award-s-recog... | Vetter Receives Corporate Health Award’s Recognition of Excellence |
/201712051689/agendia-collaborates-with-prestigious-cancer-c... | Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint® BluePrint® Breast Cancer Kit Co-Validation ... |
/201712011688/polyganics-awarded-1-2-million-to-complete-cli... | Polyganics Awarded €1.2 Million to Complete Clinical Development of Dura Sealant Patch |
/201711301687/new-data-at-the-san-antonio-breast-cancer-symp... | New Data at the San Antonio Breast Cancer Symposium Demonstrate the Value of MammaPrint® and BluePrint® Across Breast Cancer P... |
/201711301686/selvita-promotes-edyta-jaworska-to-the-managem... | Selvita Promotes Edyta Jaworska to the Management Board to Strengthen Development in Integrated Drug Discovery Services |
/201711301685/orchard-therapeutics-announces-expansion-of-te... | Orchard Therapeutics Announces Expansion of Technical Operations in California |
/201711291684/second-sartorius-research-xchange-forum-focuse... | Second Sartorius Research Xchange Forum Focuses On Regenerative Medicine and Cell Therapy |
/201711281683/agendia-s-mammaprint-breast-cancer-risk-of-rec... | Agendia’s MammaPrint® Breast Cancer Risk-of-Recurrence Test Obtains Favorable Final Payment Determination from CMS for New, Uniq... |
/201711281682/sotio-broadens-its-phase-ii-clinical-trial-pro... | SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer |
/201711281681/nbe-therapeutics-appoints-dr-nicole-onetto-to-... | NBE-Therapeutics Appoints Dr. Nicole Onetto to Its Board of Directors |
/201711281680/cristal-therapeutics-awarded-2-5-million-horiz... | Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials |
/201711271679/orchard-therapeutics-announces-extension-of-it... | Orchard Therapeutics Announces Extension of its Collaboration with Manchester University to Include Sanfilippo Syndrome Type B |
/201711211677/lead-pharma-achieves-third-milestone-in-sanofi... | Lead Pharma Achieves Third Milestone in Sanofi Collaboration for Development of Autoimmune Diseases Treatments |
/201711201676/ajcc-confirms-mammaprints-clinical-utility-for... | AJCC Confirms MammaPrint's Clinical Utility for Treatment Decisions and Staging in Recent 8th Edition Breast Chapter Update |
/201711201675/leon-nanodrugs-congratulates-its-partner-mjr-p... | leon-nanodrugs Congratulates its Partner MJR Pharmjet on Receiving Prestigious CPhI Award 2017 for Highly Innovative MicroJet Re... |
/201711171674/successful-first-in-human-testing-of-implandat... | Successful First-in-Human Testing of Implandata’s Next Generation EYEMATE™ Micro-Sensor for Improved Monitoring of Glaucoma Pati... |
/201711091672/vetter-expands-its-footprint-in-asia-pacific-r... | Vetter Expands its Footprint in Asia Pacific Region |
/201711091673/redhill-biopharma-announces-last-patient-enrol... | RedHill Biopharma Announces Last Patient Enrolled in the Phase III Study with RHB-104 for Crohn's Disease |
/201711091671/apceth-biopharma-appoints-a-new-supervisory-bo... | apceth Biopharma Appoints a New Supervisory Board |
/201711091670/neogenomics-europe-sa-opens-its-doors-in-rolle... | NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Governm... |
/201711061669/sotio-completes-enrolment-of-phase-iii-viable-... | SOTIO Completes Enrolment of Phase III VIABLE Study in Late Stage Prostate Cancer |
/201711031668/celonic-acquires-glycotopes-bio-manufacturing-... | Celonic Acquires Glycotope’s Bio-manufacturing Facility |
/201711011667/redhill-biopharma-and-intelgenx-submit-new-dru... | RedHill Biopharma and IntelGenx Submit New Drug Application to FDA for RIZAPORT® for Migraines |
/201711011666/cristal-therapeutics-progresses-nanomedicine-c... | Cristal Therapeutics Progresses Nanomedicine CriPec®-docetaxel to Phase 1b Development in Patients with Solid Tumours |
/201710311665/biogeneration-ventures-fund-iii-reaches-eur-82... | BioGeneration Ventures Fund III Reaches EUR 82 Million in Final Close |
/201710241664/sartorius-stedim-biotech-wins-frost-a-sullivan... | Sartorius Stedim Biotech Wins Frost & Sullivan Award for Customer Service Leadership in Bioanalytical Contract Testing |
/201710241663/neogenomics-announces-the-opening-of-its-first... | NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland to Support Clinical Trials |
/201710241662/corflow-completes-the-first-close-of-the-seed-... | CorFlow Completes the First Close of the Seed+ Financing Round |
/201710191661/vetter-to-expand-its-secondary-packaging-servi... | Vetter To Expand its Secondary Packaging Service Capacity to Meet Rising Demands |
/201710191660/dcprime-and-apceth-biopharma-gmbh-announce-man... | DCPrime and apceth Biopharma GmbH Announce Manufacturing Partnership |
/201710171659/the-netherlands-cancer-institute-awarded-fundi... | The Netherlands Cancer Institute Awarded Funding to Apply Molecular Imaging Technology to Prostate Cancer Surgery |
/201710161658/batavia-biosciences-expands-its-viral-vector-a... | Batavia Biosciences Expands its Viral Vector and GMP Facilities to Accommodate Increasing Market Demand |
/201710161657/antabio-raises-73m-series-a-financing-to-devel... | ANTABIO Raises € 7.3M Series A Financing to Develop Novel Treatments against Drug-Resistant Gram-Negative Infections |
/201710111656/mc2-therapeutics-as-announces-first-patient-do... | MC2 Therapeutics A/S Announces First Patient Dosed in Pivotal US Phase 3 Trial in Psoriasis Vulgaris |
/201710101655/ce-marking-for-worlds-only-integrated-hiv-self... | CE Marking for World’s Only Integrated HIV Self-Test from Atomo Diagnostics Gives Access to Safe, Accurate and Reliable Self-Tes... |
/201710091654/oncoarendi-therapeutics-to-begin-the-phase-1-c... | OncoArendi Therapeutics to Begin the Phase 1 Clinical Evaluation of its Novel Class of Medicines |
/201710051653/regulatory-approval-in-europe-granted-for-synt... | Regulatory Approval in Europe Granted for Synthon's Glatiramer Acetate 40 mg/ml |
/201710051652/chiome-bioscience-selects-probiogen-for-glymax... | Chiome Bioscience Selects ProBioGen for GlymaxX® Antibody Manufacturing Program |
/201710041651/rentschler-biotechnologie-gmbh-announces-trans... | Rentschler Biotechnologie GmbH Announces Transition into a European Corporation Called Rentschler Biopharma SE |
/201710041650/immatics-receives-usd-58-million-in-financing-... | Immatics Receives USD 58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies |
/201710031649/redhill-biopharma-announces-positive-top-line-... | RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irr... |
/201710021647/dutch-mellon-medical-secures-6-million-for-mar... | Dutch Mellon Medical Secures € 6 Million for Market Introduction of Major Innovation in Surgical Suture Technology: Single-Hande... |
/201710021646/pnuvax-awarded-294-million-usd-grant-to-advanc... | PnuVax Awarded USD29.4 Million USD Grant to Advance Innovative Vaccine into Clinical Trials |
/201710021648/redhill-biopharma-accelerates-rhb-104-phase-ii... | RedHill Biopharma Accelerates RHB-104 Phase III Study in Crohn’s Disease with Top-Line Results Expected Mid-2018 |
/201709281645/vetter-lays-the-foundation-for-a-state-of-the-... | Vetter Lays the Foundation for a State-of-the-Art Administration Building |
/201709271644/swiss-biotech-association-strengthens-its-boar... | Swiss Biotech Association Strengthens Its Board of Directors and Appoints Michael Altorfer As Its New CEO |
/201709271643/rfxcel-drives-eu-expansion-with-industry-exper... | rfxcel Drives EU Expansion with Industry Experts |
/201709211642/oncoqr-mls-vaccine-platform-closes-the-final-g... | OncoQR ML's Vaccine Platform Closes the Final Gap in the Immunological Attack Against Cancer |
/201709201641/sgi-dna-and-biocat-announce-distribution-partn... | SGI-DNA and BioCat Announce Distribution Partnership for Vmax™ Express Protein Expression Platform |
/201709191640/molecular-devices-and-cytena-partner-to-launch... | Molecular Devices and Cytena Partner to Launch the CloneSelect Single-Cell Printer |
/201709191639/aplagon-partners-with-cadila-pharmaceuticals-t... | Aplagon Partners with Cadila Pharmaceuticals to Develop and Commercialize APAC First-in-Class Antithrombotics for the Prevention... |
/201709181638/varmx-announces-publication-in-nature-communic... | VarmX Announces Publication in Nature Communications of Groundbreaking Snake Venom Inspired Approach to Restore Blood Clotting i... |
/201709181637/new-in-situ-hydrolysis-spe-plates-from-biotage... | New In-situ Hydrolysis SPE Plates from Biotage |
/201709181636/shuwen-biotech-receives-ce-mark-for-egfr-mutat... | Shuwen Biotech Receives CE Mark for EGFR Mutation PCR Kit for Lung Cancer |
/201709141635/levicept-starts-first-in-human-phase-i-trial-o... | Levicept Starts First-in-Human Phase I Trial of LEVI-04, A Novel Fusion Protein Therapy for Chronic Pain |
/201709131634/der-sartorius-campus-waechst-einweihung-des-ne... | Der Sartorius Campus wächst: Einweihung des neuen Produktionsgebäudes für Laborinstrumente |
/201709131633/redhill-biopharma-initiates-promotion-of-esome... | RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S. |
/201709131632/european-patent-office-decides-in-synthons-fav... | European Patent Office Decides in Synthon's Favor in Glatiramer Patent Case |
/201710261631/sartorius-stedim-biotech-wins-frost-sullivan-a... | Invicro Acquires Imanova to Expand Global Imaging Capabilities |
/201709121630/successful-industrial-gmp-manufacturing-of-rib... | Successful Industrial GMP Manufacturing of RIBOXXIM, a Novel and Highly Potent Toll-like 3 Ligand for Immunotherapy of Cancer |
/201709111629/new-analysis-from-german-study-group-prospecti... | New Analysis from German Study Group Prospective Trial Shows Minimal Distant Recurrence in Patients with Clinically High-Risk Br... |
/201709201628/test.html | Robust Performance of OncoBEAM™ RAS CRC Liquid Biopsy Testing in Routine Clinical Practice for Colorectal Cancer Patients Highli... |
/201709061627/congenicas-sapientia-selected-by-coimbra-paedi... | Congenica’s Sapientia™ Selected by Coimbra Paediatric Hospital for Portugal’s In2Genome Genetic Disease Diagnosis Project |
/201709051626/amal-therapeutics-raises-eur-8-million-chf-8-8... | AMAL Therapeutics Raises EUR 8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round |
/201709011625/asian-study-of-over-15000-mammograms-underline... | Asian Study of Over 15,000 Mammograms Underlines the Potential Value of Sigmascreening’s Sensitive Sigma™ Paddle Solution for Pr... |
/201708221624/orchard-therapeutics-announces-that-otl-101-ha... | Orchard Therapeutics Announces That OTL-101 Has Received a Designation as Promising Innovative Medicine by UK’s Regulatory Agenc... |
/201708211623/immatics-initiates-personalized-adoptive-cellu... | Immatics Initiates Personalized Adoptive Cellular Therapy in Patients with Relapsed And/Or Refractory Solid Cancers Using Its Pi... |
/201708171622/redhill-biopharma-announces-us-commercializati... | RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release ... |
/201708161621/mimetas-develops-high-throughput-gut-on-a-chip... | MIMETAS Develops High-Throughput Gut-on-a-chip Technology in Collaboration with Pharmaceutical Company |
/201708101620/redhill-biopharma-provides-2017-semi-annual-bu... | RedHill Biopharma Provides 2017 Semi-Annual Business Update |
/201708101619/orchard-therapeutics-appoints-mark-rothera-as-... | Orchard Therapeutics Appoints Mark Rothera as CEO |
/201707311618/redhill-biopharma-announces-unanimous-positive... | RedHill Biopharma Announces Unanimous Positive DSMB Recommendation for Continuation of the Phase III Study with RHB-104 for Croh... |
/201707311617/bioscience-managers-appoints-elizabeth-klein-a... | BioScience Managers Appoints Elizabeth Klein as Investment Consultant in the UK to Support BioScience Managers' and Downing's Li... |
/201707251616/biogenes-celebrates-25-years-of-excellence-in-... | BioGenes Celebrates 25 Years of Excellence in Quality Control of Biotherapeutics |
/201707251615/unicyte-ag-regenerative-medicine-unit-of-frese... | Unicyte AG, Regenerative Medicine Unit of Fresenius Medical Care, Appoints World-Leading Experts to Scientific Advisory Board |
/201707251614/antabio-awarded-up-to-89m-from-carb-x-to-accel... | ANTABIO Awarded Up to USD8.9M from CARB-X to Accelerate the Development of Its New Treatment For Chronic Infections in Cystic Fi... |
/201707241613/orchard-therapeutics-announces-that-otl-101-ha... | Orchard Therapeutics Announces That OTL-101 Has Received a Rare Paediatric Disease Designation |
/201707171612/redhill-biopharma-announces-last-patient-visit... | RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D |
/201707171611/new-study-presented-at-alzheimers-association-... | New Study Presented at Alzheimer’s Association International Conference 2017 (AAIC) Validates Equivalency of Pen-and-Paper Cogni... |
/201707121610/redhill-biopharma-announces-expected-timeline-... | RedHill Biopharma Announces Expected Timeline for DSMB Meeting and Provides Update on Enrollment in the RHB-104 Phase III Study ... |
/201707121609/genomic-health-updated-st-gallen-international... | Genomic Health: Updated St. Gallen International Breast Cancer Guidelines Reinforce Important Role of Genomic Testing in Treatme... |
/201707111608/daiichi-sankyo-max-planck-innovation-and-lead-... | Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center Announce Cancer Research Collaboration |
/201707101607/agendias-mammaprintr-recommended-by-asco-breas... | Agendia’s MammaPrint® Recommended by ASCO Breast Cancer Guideline in Focused Update Based on Landmark MINDACT Trial Data |
/201707051606/nature-publication-for-cellmids-midkine-in-can... | Nature Publication for Cellmid’s Midkine in Cancer |
/201706291605/new-second-generation-solvent-evaporators-from... | New Second Generation Solvent Evaporators from Biotage |
/201706281604/merlion-and-dstl-awarded-dtra-grant-to-explore... | MerLion and Dstl Awarded DTRA Grant to Explore the Use of Finafloxacin against Biological Threat Agents |
/201706271603/sartorius-and-science-magazine-to-award-prize-... | Sartorius and Science Magazine to Award Prize for Regenerative Medicine and Cell Therapy |
/201706271602/biogeneration-ventures-fund-iii-secures-eur-66... | BioGeneration Ventures Fund III Secures EUR 66m, Exceeding EUR 50m Target |
b3cnewswire.com/?rCH=2 | Ok |
[Querying whois.verisign-grs.com]
[Redirected to whois.1api.net]
[Querying whois.1api.net]
[whois.1api.net]
Domain Name: B3CNEWSWIRE.COM
Registry Domain ID:
Registrar WHOIS Server: whois.1api.net
Registrar URL: http://www.1api.net
Updated Date: 2011-07-04T08:07:59Z
Creation Date: 2007-07-04T14:12:45Z
Registrar Registration Expiration Date: 2014-07-04T14:12:45Z
Registrar: 1api GmbH
Registrar IANA ID: 1387
Registrar Abuse Contact Email: abuse@1api.net
Registrar Abuse Contact Phone: +49.68416984x200
Reseller: Hostmaster of the Day http://www.varioserver.de
Domain Status: clientTransferProhibited
Registry Registrant ID:
Registrant Name: Sabine Dr. Duntze
Registrant Organization:
Registrant Street: Seuffertstr. 5
Registrant City: Traunstein
Registrant State/Province:
Registrant Postal Code: 83278
Registrant Country: DE
Registrant Phone: +49.8619098220
Registrant Phone Ext:
Registrant Fax: +49.8619098220
Registrant Fax Ext:
Registrant Email: sduntze@b3c.de
Registry Admin ID:
Admin Name: Sabine Dr. Duntze
Admin Organization: B3C Group GmbH
Admin Street: Seestrasse 40
Admin City: Eich
Admin State/Province:
Admin Postal Code: 6205
Admin Country: CH
Admin Phone: +41.416122110
Admin Phone Ext:
Admin Fax: +41.416122111
Admin Fax Ext:
Admin Email: sd@b3cgroup.com
Registry Tech ID:
Tech Name: Michael Weichselgartner
Tech Organization: WebControl GmbH
Tech Street: Schimmelbuschstr. 9
Tech City: Erkrath
Tech State/Province:
Tech Postal Code: 40699
Tech Country: DE
Tech Phone: +49.210413940
Tech Phone Ext:
Tech Fax: +49.2104139499
Tech Fax Ext:
Tech Email: domreg@webcontrol.de
Name Server: ns1.securewebs.net 213.218.161.254 2a00:6480:0001:0001:0000:0000:0000:0010
Name Server: ns2.securewebs.net 84.254.64.4
DNSSEC:
URL of the ICANN WHOIS Data Problem Reporting System:
http://wdprs.internic.net/
>>> Last update of WHOIS database: 2014-02-20T16:55:24Z
# If the Joomla site is installed within a folder
# eg www.example.com/joomla/ then the robots.txt file
# MUST be moved to the site root
# eg www.example.com/robots.txt
# AND the joomla folder name MUST be prefixed to all of the
# paths.
# eg the Disallow rule for the /administrator/ folder MUST
# be changed to read
# Disallow: /joomla/administrator/
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/orig.html
#
# For syntax checking, see:
# http://tool.motoricerca.info/robots-checker.phtml
User-agent: *
Disallow: /administrator/
Disallow: /bin/
Disallow: /cache/
Disallow: /cli/
Disallow: /components/
Disallow: /includes/
Disallow: /installation/
Disallow: /language/
Disallow: /layouts/
Disallow: /libraries/
Disallow: /logs/
Disallow: /modules/
Disallow: /plugins/
Disallow: /tmp/
США - Майами - 63.251.144.201
Internap Network Services Corporation
Internap Network Services Corporation
HTTP/1.1 200 OK
Server: nginx
Date: Thu, 05 Dec 2019 22:59:15 GMT
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
Vary: Accept-Encoding
Expires: Wed, 17 Aug 2005 00:00:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Set-Cookie: 077d4daa32e0d5a21ccd8d8214b89d28=7c483033cf797e625b04be56325adf5e; path=/; secure; HttpOnly
X-Content-Type-Options: nosniff
Last-Modified: Thu, 05 Dec 2019 22:59:15 GMT
Vary: Accept-Encoding
X-Powered-By: PleskLin
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"